These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 37936892)
1. Mesoporous polydopamine delivery system for intelligent drug release and photothermal-enhanced chemodynamic therapy using MnO Wang Z; Li Z; Shi Y; Zeng L Regen Biomater; 2023; 10():rbad087. PubMed ID: 37936892 [TBL] [Abstract][Full Text] [Related]
2. MRI-guided dual-responsive anti-tumor nanostructures for synergistic chemo-photothermal therapy and chemodynamic therapy. Shi Y; Zhou M; Zhang Y; Wang Y; Cheng J Acta Biomater; 2023 Mar; 158():571-582. PubMed ID: 36586501 [TBL] [Abstract][Full Text] [Related]
3. Mesoporous polydopamine-based nanoplatform for enhanced tumor chemodynamic therapy through the reducibility weakening strategy. Zhang Q; Xu X; Yang Q; Duan Y; Chen C; Zhao S; Ouyang Y; Chen Y; Cao Y; Liu H Colloids Surf B Biointerfaces; 2023 Feb; 222():113091. PubMed ID: 36542951 [TBL] [Abstract][Full Text] [Related]
4. Hollow mesoporous MnO He H; Yang Q; Li H; Meng S; Xu Z; Chen X; Sun Z; Jiang B; Li C Mikrochim Acta; 2021 Mar; 188(4):141. PubMed ID: 33774694 [TBL] [Abstract][Full Text] [Related]
5. Tumor microenvironment responsive theranostic agent for enhanced chemo/chemodynamic/photothermal therapy. Wang J; Kong W; Jin H; Li C; Luo Q; Luo Y; Yuan C; Lu J; Zhang L; Liu X Colloids Surf B Biointerfaces; 2022 Oct; 218():112750. PubMed ID: 35961116 [TBL] [Abstract][Full Text] [Related]
6. H Xiao Z; Zuo W; Chen L; Wu L; Liu N; Liu J; Jin Q; Zhao Y; Zhu X ACS Appl Mater Interfaces; 2021 Sep; 13(37):43925-43936. PubMed ID: 34499485 [TBL] [Abstract][Full Text] [Related]
7. Ultrasmall Gold-Coated Mesoporous Polydopamine Nanoprobe to Enhance Chemodynamic Therapy by Self-Supplying H Wang Z; Shi Y; Shi Y; Zhang J; Hao R; Zhang G; Zeng L ACS Appl Mater Interfaces; 2022 Dec; 14(49):54478-54487. PubMed ID: 36448730 [TBL] [Abstract][Full Text] [Related]
8. Endo/exo-genous dual-stimuli responsive gold nanotetrapod-based nanoprobe for magnetic resonance imaging and enhanced multimodal therapeutics by amplifying·OH generation. Shi Y; Zeng L; Pan Y; Zhang H; Wang Z; Shi Y; Wu A Acta Biomater; 2022 Dec; 154():549-558. PubMed ID: 36243375 [TBL] [Abstract][Full Text] [Related]
9. Tumor microenvironment-responsive versatile "Trojan horse" theranostic nanoplatform for magnetic resonance imaging-guided multimodal synergistic antitumor treatment. Huang Q; Pan Y; Wang M; Liu Z; Chen H; Wang J; Zhao Z; Zhang Y Acta Biomater; 2022 Jul; 147():270-286. PubMed ID: 35595202 [TBL] [Abstract][Full Text] [Related]
11. A biocompatible theranostic agent based on stable bismuth nanoparticles for X-ray computed tomography/magnetic resonance imaging-guided enhanced chemo/photothermal/chemodynamic therapy for tumours. Zhao H; Wang J; Li X; Li Y; Li C; Wang X; Wang J; Guan S; Xu Y; Deng G; Chen Y; Lu J; Liu X J Colloid Interface Sci; 2021 Dec; 604():80-90. PubMed ID: 34265694 [TBL] [Abstract][Full Text] [Related]
12. Hyaluronic acid-modified manganese dioxide-enveloped hollow copper sulfide nanoparticles as a multifunctional system for the co-delivery of chemotherapeutic drugs and photosensitizers for efficient synergistic antitumor treatments. Li X; Pan Y; Zhou J; Yi G; He C; Zhao Z; Zhang Y J Colloid Interface Sci; 2022 Jan; 605():296-310. PubMed ID: 34329981 [TBL] [Abstract][Full Text] [Related]
14. Precisely NIR-II-activated and pH-responsive cascade catalytic nanoreactor for controlled drug release and self-enhanced synergetic therapy. Hu P; Zhao S; Shi J; Li F; Wang S; Gan Y; Liu L; Yu S Nanoscale; 2022 Sep; 14(34):12219-12231. PubMed ID: 35582977 [TBL] [Abstract][Full Text] [Related]
15. Fabrication of doxorubicin-gated mesoporous polydopamine nanoplatforms for multimode imaging-guided synergistic chemophotothermal therapy of tumors. Yang M; Zhang N; Zhang T; Yin X; Shen J Drug Deliv; 2020 Dec; 27(1):367-377. PubMed ID: 32091284 [TBL] [Abstract][Full Text] [Related]
16. In vitro Antitumor Properties of Fucoidan-Coated, Doxorubicin-Loaded, Mesoporous Polydopamine Nanoparticles. Xu H; Ling J; Zhao H; Xu X; Ouyang XK; Song X Molecules; 2022 Dec; 27(23):. PubMed ID: 36500550 [TBL] [Abstract][Full Text] [Related]
17. Biomimetic Yolk-Shell Nanocatalysts for Activatable Dual-Modal-Image-Guided Triple-Augmented Chemodynamic Therapy of Cancer. Pan Y; Zhu Y; Xu C; Pan C; Shi Y; Zou J; Li Y; Hu X; Zhou B; Zhao C; Gao Q; Zhang J; Wu A; Chen X; Li J ACS Nano; 2022 Nov; 16(11):19038-19052. PubMed ID: 36315056 [TBL] [Abstract][Full Text] [Related]
18. A mesoporous MnO Zhang HL; Wang Y; Tang Q; Ren B; Yang SP; Liu JG J Inorg Biochem; 2023 Apr; 241():112133. PubMed ID: 36708626 [TBL] [Abstract][Full Text] [Related]
19. Sialic acid-engineered mesoporous polydopamine nanoparticles loaded with SPIO and Fe Shu G; Chen M; Song J; Xu X; Lu C; Du Y; Xu M; Zhao Z; Zhu M; Fan K; Fan X; Fang S; Tang B; Dai Y; Du Y; Ji J Bioact Mater; 2021 May; 6(5):1423-1435. PubMed ID: 33210034 [TBL] [Abstract][Full Text] [Related]
20. A tetrasulfide bond-bridged mesoporous organosilica-based nanoplatform for triple-enhanced chemodynamic therapy combined with chemotherapy and H Liu M; Xu H; Zhou F; Gong X; Tan S; He Y J Mater Chem B; 2023 Nov; 11(45):10822-10835. PubMed ID: 37920970 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]